Skip to main content

Alimir Piros

Analyst

Lucid Capital Markets

Equibles does not estimate personal net worth.

About Alimir Piros

Alimir Piros is recorded as Analyst at Lucid Capital Markets. Alimir Piros has spoken on 1 investor event across 1 company, most recently for NRX Pharmaceuticals, Inc. on October 30, 2026. The companies whose calls Alimir Piros spoke on are classified in the Healthcare sector.

Alimir Piros on recent calls

“You talked about three different channels. How do you envision the distribution or the proportion of revenue coming through these three channels, approximately?”
Analyst — Lucid Capital Markets, NRx Pharmaceuticals Conference Call to Discuss Regulatory Milestone for Preservative-Free Ketamine ·

Affiliation history

  • Lucid Capital Markets

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity